Sicart Associates LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001696494

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHigh Turnover how tags are computed

Q1 2024 · 76 positions · Total reported value $273.02M · Top-10 concentration 44.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 41.8% · 5 new · 22 cut · 6 exited

Active Share (vs S&P 500): 84.4% · vs QQQ: 85.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.8% · vs SPY -3.9% · Prev Value $408.40M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.2% · vs SPY -3.4% · Latest Value $412.55M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Sicart Associates LLC disclosed 76 equity positions with a combined reported value of $273.02M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.0% of reported value. HoldingsHub classifies the profile as Small / High Turnover.

The largest disclosed positions as of Q1 2024 were GLD ($21.50M), META ($16.95M), NFLX ($15.64M). By sector, the heaviest allocations are Consumer Discretionary 24.6%, Technology 18.8%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+2.0pp) and away from Consumer Staples (-0.5pp), Health Care (-0.6pp).

Versus the prior quarter, Sicart Associates LLC opened 5 new positions, trimmed 22 and fully exited 6, a turnover rate of 41.8% of positions. The portfolio's overlap with the prior quarter was 90% of names.

The largest new positions opened in Q1 2024 were IBB ($1.20M), CGON ($1.10M), MGK ($241.04K).

Of the 6 positions fully exited versus the prior quarter, the largest were RBLX ($225.40K), SNOW ($200.19K), TSPH ($12.00K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • IBB ISHARES TR · $1.20M
  • CGON CG ONCOLOGY INC · $1.10M
  • MGK VANGUARD MEGA · $241.04K
  • NVO NOVO-NORDISK A S · $219.86K
  • VONG VANGUARD RUSSELL · $207.66K

Fully Exited (vs previous quarter)

  • RBLX ROBLOX CORP · prev qtr: $225.40K
  • SNOW SNOWFLAKE INC · prev qtr: $200.19K
  • TSPH TUSIMPLE HLDGS INC · prev qtr: $12.00K

Insider Transactions (Form 4)

Latest Sicart Associates LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sicart Associates LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 74 positions worth $408.40M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-108418 (status: Approved), registered 2016-09-29
  • Regulatory AUM (Form ADV): $455.38M as of 2026-04-07
  • Client mix (by RAUM): individual investors 95%, pension and profit-sharing plans 5%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 74 positions · $408.40M reported value (Q2 2026)
  • Top 10 holdings = 51.0% of reported value
  • Largest position: BIL (SPDR SERIES TRUST) at 8.6%
  • Average position size: $5.52M

Sector Tilt

  • Health Care 18.3%
  • Information Technology 14.1%
  • Consumer Discretionary 12.7%
  • (classified holdings cover 81% of value)

Quarterly Activity

  • Q2 2026: 4 new, 8 added, 21 reduced, 4 exited
  • 41 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 18.8%
Health Care 12.0%
Financials 11.1%
Energy 3.2%
Other 10.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 104.53K $21.50M 7.88%
7.88%
Reduce
2 34.91K $16.95M 6.21%
6.21%
Reduce
3 25.75K $15.64M 5.73%
5.73%
Reduce
4 289.36K $10.68M 3.91%
3.91%
Reduce
5 32.22K $9.38M 3.43%
3.43%
Reduce
6 56.74K $9.36M 3.43%
3.43%
Reduce
7 114.53K $9.30M 3.41%
3.41%
Reduce
8 61.25K $9.24M 3.39%
3.39%
Reduce
9 88.93K $9.12M 3.34%
3.34%
Reduce
10 68.09K $9.00M 3.30%
3.30%
Reduce
11 193.99K $8.41M 3.08%
3.08%
Hold
12 111.97K $8.20M 3.00%
3.00%
Reduce
13 182.21K $8.05M 2.95%
2.95%
Reduce
14 145.24K $8.00M 2.93%
2.93%
Hold
15 59.72K $7.31M 2.68%
2.68%
Reduce
16 124.28K $7.20M 2.64%
2.64%
Reduce
17 79.77K $7.01M 2.57%
2.57%
Reduce
18 55.40K $6.20M 2.27%
2.27%
Hold
19 10.03K $5.06M 1.85%
1.85%
Reduce
20 80.76K $4.98M 1.82%
1.82%
Reduce
21 90.57K $4.98M 1.82%
1.82%
Hold
22 25.00K $4.29M 1.57%
1.57%
Hold
23 124.07K $4.09M 1.50%
1.50%
Add
24 61.29K $4.01M 1.47%
1.47%
Reduce
25 122.19K $3.97M 1.45%
1.45%
Reduce
26 25.13K $3.85M 1.41%
1.41%
Reduce
27 41.67K $3.83M 1.40%
1.40%
Reduce
28 52.34K $3.51M 1.28%
1.28%
Reduce
29 76.43K $3.40M 1.24%
1.24%
Reduce
30 146.59K $3.02M 1.11%
1.11%
Add
31 780 $2.83M 1.04%
1.04%
Hold
32 5.71K $2.75M 1.01%
1.01%
Hold
33 705.18K $2.63M 0.96%
0.96%
Hold
34 41.97K $2.53M 0.93%
0.93%
Hold
35 18.07K $2.48M 0.91%
0.91%
Add
36 134.50K $2.37M 0.87%
0.87%
Reduce
37 164.93K $2.36M 0.86%
0.86%
Reduce
38 107.70K $2.34M 0.86%
0.86%
Reduce
39 67.33K $1.87M 0.69%
0.69%
Hold
40 20.15K $1.84M 0.67%
0.67%
Add
41 9.01K $1.62M 0.59%
0.59%
Hold
42 4.64K $1.52M 0.56%
0.56%
Reduce
43 12.60K $1.39M 0.51%
0.51%
Reduce
44 4.60K $1.30M 0.47%
0.47%
Hold
45 8.78K $1.20M 0.44%
0.44%
New
46 25.00K $1.10M 0.40%
0.40%
New
47 9.35K $1.09M 0.40%
0.40%
Add
48 109.04K $903.92K 0.33%
0.33%
Reduce
49 31.77K $722.72K 0.27%
0.27%
Hold
50 5.20K $604.80K 0.22%
0.22%
Hold

FAQ

What did Sicart Associates LLC buy in 2024-Q1?

In its 2024-Q1 13F filing, Sicart Associates LLC reported 76 equity positions worth $273.02M in aggregate; its largest disclosed positions were GLD ($21.50M), META ($16.95M), NFLX ($15.64M).

How large is Sicart Associates LLC's portfolio?

Sicart Associates LLC reported $273.02M of long equity holdings across 76 positions as of 2024-Q1. Top-10 holdings account for 44.0% of reported value.

What is Sicart Associates LLC's investment style?

HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sicart-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →